Found: 129
Select item for more details and to access through your institution.
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 1, p. 3, doi. 10.1177/2040620716678118
- By:
- Publication type:
- Article
Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1023, doi. 10.3390/cancers16051023
- By:
- Publication type:
- Article
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
- By:
- Publication type:
- Article
Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143330
- By:
- Publication type:
- Article
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5770, doi. 10.3390/cancers13225770
- By:
- Publication type:
- Article
Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 5, p. 201, doi. 10.1007/s11899-023-00705-8
- By:
- Publication type:
- Article
Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?
- Published in:
- Current Hematologic Malignancy Reports, 2017, v. 12, n. 4, p. 309, doi. 10.1007/s11899-017-0393-y
- By:
- Publication type:
- Article
Nuances in the Management of Older People With Multiple Myeloma.
- Published in:
- Current Hematologic Malignancy Reports, 2016, v. 11, n. 3, p. 241, doi. 10.1007/s11899-016-0323-4
- By:
- Publication type:
- Article
Pharmacoeconomic Implications of Lenalidomide Maintenance Therapy in Multiple Myeloma.
- Published in:
- Oncology, 2014, v. 87, n. 4, p. 224, doi. 10.1159/000364880
- By:
- Publication type:
- Article
Outcome Disparities among Ethnic Subgroups of Waldenström's Macroglobulinemia: A Population-Based Study.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Outcome Disparities among Ethnic Subgroups of Waldenström's Macroglobulinemia: A Population-Based Study.
- Published in:
- Oncology, 2014, v. 86, n. 5/6, p. 253, doi. 10.1159/000360992
- By:
- Publication type:
- Article
Erlotinib for Metastatic Non-Small-Cell Lung Cancer: First-, Second- or Third-Line Setting – Does It Matter ?
- Published in:
- Oncology, 2009, v. 76, n. 2, p. 85, doi. 10.1159/000187427
- By:
- Publication type:
- Article
Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2006, v. 70, n. 1, p. 49, doi. 10.1159/000091184
- By:
- Publication type:
- Article
Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1076, doi. 10.1634/theoncologist.2017-0592
- By:
- Publication type:
- Article
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01129-0
- By:
- Publication type:
- Article
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
- By:
- Publication type:
- Article
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01067-x
- By:
- Publication type:
- Article
Global disparities in patients with multiple myeloma: a rapid evidence assessment.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00877-9
- By:
- Publication type:
- Article
Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 358, doi. 10.1016/j.clml.2024.02.004
- By:
- Publication type:
- Article
Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 5, p. e217, doi. 10.1016/j.clml.2024.01.014
- By:
- Publication type:
- Article
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
- By:
- Publication type:
- Article
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 3, p. 149, doi. 10.1016/j.clml.2021.08.007
- By:
- Publication type:
- Article
P-136: Health-related quality of life (HRQL) among real-world Ide-Cel–eligible patients (pts) with relapsed/refractory Multiple Myeloma (RRMM): results from the Connect® MM registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S109, doi. 10.1016/S2152-2650(21)02263-1
- By:
- Publication type:
- Article
MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S428, doi. 10.1016/S2152-2650(21)01955-8
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: MM-200: A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S255, doi. 10.1016/S2152-2650(21)01598-6
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
- By:
- Publication type:
- Article
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
- By:
- Publication type:
- Article
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CLR 131 Demonstrates High Rate of Activity in a Phase 1, Dose Escalation Study in Patients with Relapsed or Refractory Multiple Myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e356, doi. 10.1016/j.clml.2019.09.589
- By:
- Publication type:
- Article
Carfilzomib-based induction improves progression free survival and rate of minimal residual disease negativity following autologous transplant in high risk multiple myeloma patients: a retrospective analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e217, doi. 10.1016/j.clml.2019.09.361
- By:
- Publication type:
- Article
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e74, doi. 10.1016/j.clml.2019.09.118
- By:
- Publication type:
- Article
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e75, doi. 10.1016/j.clml.2019.09.119
- By:
- Publication type:
- Article
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Single-Center Experience of Axicabtagene Ciloleucel CAR-T Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S267, doi. 10.1016/j.clml.2019.07.191
- By:
- Publication type:
- Article
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ENESTfreedom and ENESTop Update: Durable Treatment-Free Remission (TFR) at 96 Weeks after Nilotinib Treatment Cessation in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S314, doi. 10.1016/j.clml.2017.07.115
- By:
- Publication type:
- Article
Influence of Obesity on Outcomes of Patients with Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e139, doi. 10.1016/j.clml.2017.03.252
- By:
- Publication type:
- Article
Treatment-Free Remission (TFR) Following Frontline or Second-Line Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTfreedom and ENESTop.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S64, doi. 10.1016/j.clml.2016.07.094
- By:
- Publication type:
- Article
Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article